Scientific Sessions 2024  /  Translating 'Almost' 100 Years of Lipoprotein Research: Current and Future Lipoprotein Interventions - Its All in the Mechanism  /  Cardiovascular Residual Risk: Case Presentation
Logo

American Heart Association

  111
  0

Final ID:

Cardiovascular Residual Risk: Case Presentation

  • Maqsood, Muhammad Haisum  ( Houston Methodist Hospital , Houston , Texas , United States )
  • Safarova, Maya  ( The Medical College of Wisconsin , Brookfield , Wisconsin , United States )
    • Author Disclosures:
    Muhammad Haisum Maqsood: DO NOT have relevant financial relationships | Maya Safarova: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Translating 'Almost' 100 Years of Lipoprotein Research: Current and Future Lipoprotein Interventions - Its All in the Mechanism

Sunday, 11/17/2024 , 03:30PM - 04:45PM

Cardiovascular Seminar

More abstracts on this topic:
The future of HDL modifying therapies

Davidson William, Marsche Gunther

The past, present, and future of lipoprotein-targeting therapies

Remaley Alan, Young Stephen

More abstracts from these authors:
Suicide and Self-Harm with GLP-1 Receptor Agonists: A Meta-Analysis of Randomized Controlled Trials

Hosseini Kaveh, Heffron Sean, Ebrahimi Pouya, Batlle Juan, Maqsood Muhammad Haisum, Ayati Aryan, Long Clarine, Mcgowan Natalie, Tarabanis Constantine, Laynor Gregory

Lipoprotein Apheresis improves HDL Proteomics and reduces the risk of Aortic Stenosis in patients with elevated Lipoprotein(a) levels and Familial Hypercholesterolemia

Moriarty Patrick, Safarova Maya

You have to be authorized to contact abstract author. Please, Login
Not Available